Patent · US Active

Endoribonuclease compositions and methods of use thereof

US9708646B2 · kind B2 · utility

1Cited by
26References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 10, 2017
Grant dateJul 18, 2017
Priority date
Expiry dateFeb 10, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q1/6816
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure provides variant Csy4 endoribonucleases, nucleic acids encoding the variant Csy4 endoribonucleases, and host cells genetically modified with the nucleic acids. The variant Csy4 endoribonucleases find use in a variety of applications, which are also provided. The present disclosure also provides methods of detecting a specific sequence in a target polyribonucleotide; and methods of regulating production of a target RNA in a eukaryotic cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.